C D Graber, J Jebaily, R L Galphin, E Doering. Show Affiliations »
Abstract
Entities: Chemical Disease Species
Mesh: See more » Antibody FormationAntigen-Antibody ReactionsHemocyaninsHumansProteinuria/etiologyRifampin/adverse effectsRifampin/therapeutic useSalmonellaTuberculosis/drug therapyTuberculosis/immunologyTuberculosis, Pulmonary/drug therapyTuberculosis, Pulmonary/immunologyVaccines
Substances: See more » VaccinesHemocyaninsRifampin
Year: 1973 PMID: 4695622 DOI: 10.1164/arrd.1973.107.5.713
Source DB: PubMed Journal: Am Rev Respir Dis ISSN: 0003-0805